Cardlytics, Inc. $CDLX Shares Purchased by Quinn Opportunity Partners LLC

Quinn Opportunity Partners LLC increased its stake in Cardlytics, Inc. (NASDAQ:CDLXFree Report) by 900.0% in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,100,000 shares of the company’s stock after acquiring an additional 990,000 shares during the quarter. Quinn Opportunity Partners LLC owned approximately 2.03% of Cardlytics worth $2,673,000 at the end of the most recent reporting period.

A number of other large investors also recently added to or reduced their stakes in the stock. Vanguard Personalized Indexing Management LLC acquired a new stake in shares of Cardlytics in the third quarter valued at about $26,000. Catalyst Funds Management Pty Ltd acquired a new position in shares of Cardlytics during the 2nd quarter worth about $32,000. Sand Hill Global Advisors LLC acquired a new position in shares of Cardlytics during the 2nd quarter worth about $35,000. Global Retirement Partners LLC lifted its stake in Cardlytics by 67.3% in the 3rd quarter. Global Retirement Partners LLC now owns 34,800 shares of the company’s stock valued at $85,000 after buying an additional 14,000 shares in the last quarter. Finally, Marshall Wace LLP purchased a new position in Cardlytics in the 2nd quarter valued at about $59,000. 68.10% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Cardlytics

In other news, CEO Amit Gupta sold 52,049 shares of the business’s stock in a transaction that occurred on Tuesday, February 17th. The stock was sold at an average price of $0.90, for a total transaction of $46,844.10. Following the transaction, the chief executive officer directly owned 704,803 shares in the company, valued at $634,322.70. The trade was a 6.88% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In the last 90 days, insiders sold 117,875 shares of company stock worth $113,022. Insiders own 4.40% of the company’s stock.

Cardlytics Stock Performance

NASDAQ:CDLX opened at $0.67 on Friday. The company’s 50-day moving average price is $1.00 and its 200-day moving average price is $1.35. The company has a current ratio of 1.75, a quick ratio of 1.75 and a debt-to-equity ratio of 2.87. The company has a market cap of $37.14 million, a P/E ratio of -0.35 and a beta of 1.03. Cardlytics, Inc. has a twelve month low of $0.66 and a twelve month high of $3.28.

Cardlytics (NASDAQ:CDLXGet Free Report) last posted its quarterly earnings results on Wednesday, March 4th. The company reported ($0.15) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.07) by ($0.08). The business had revenue of $56.10 million for the quarter, compared to analyst estimates of $54.46 million. Cardlytics had a negative return on equity of 370.98% and a negative net margin of 44.36%. On average, sell-side analysts forecast that Cardlytics, Inc. will post -1.52 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts have commented on the company. Bank of America reiterated an “underperform” rating on shares of Cardlytics in a research note on Thursday, March 5th. Weiss Ratings restated a “sell (d-)” rating on shares of Cardlytics in a research report on Monday, December 29th. Finally, Evercore set a $1.00 price target on Cardlytics in a research note on Friday, March 6th. Two equities research analysts have rated the stock with a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Reduce” and a consensus price target of $1.75.

View Our Latest Stock Analysis on CDLX

Cardlytics Company Profile

(Free Report)

Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.

At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.

Further Reading

Want to see what other hedge funds are holding CDLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardlytics, Inc. (NASDAQ:CDLXFree Report).

Institutional Ownership by Quarter for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.